Torchmark (TMK) versus Its Peers Head-To-Head Contrast

Torchmark (NYSE: TMK) is one of 38 public companies in the “Life insurance” industry, but how does it weigh in compared to its peers? We will compare Torchmark to similar businesses based on the strength of its institutional ownership, valuation, analyst recommendations, earnings, risk, dividends and profitability.

Analyst Ratings

How to Become a New Pot Stock Millionaire

This is a summary of recent recommendations for Torchmark and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Torchmark 4 3 1 0 1.63
Torchmark Competitors 317 1126 1513 83 2.45

Torchmark currently has a consensus price target of $82.25, suggesting a potential downside of 2.48%. As a group, “Life insurance” companies have a potential upside of 10.73%. Given Torchmark’s peers stronger consensus rating and higher possible upside, analysts clearly believe Torchmark has less favorable growth aspects than its peers.

Risk & Volatility

Torchmark has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Torchmark’s peers have a beta of 1.07, suggesting that their average stock price is 7% more volatile than the S&P 500.

Dividends

Torchmark pays an annual dividend of $0.64 per share and has a dividend yield of 0.8%. Torchmark pays out 13.3% of its earnings in the form of a dividend. As a group, “Life insurance” companies pay a dividend yield of 2.2% and pay out 28.7% of their earnings in the form of a dividend. Torchmark has raised its dividend for 8 consecutive years.

Profitability

This table compares Torchmark and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Torchmark 34.99% 10.81% 2.52%
Torchmark Competitors 4.44% 4.85% 0.81%

Insider and Institutional Ownership

74.7% of Torchmark shares are owned by institutional investors. Comparatively, 49.3% of shares of all “Life insurance” companies are owned by institutional investors. 3.7% of Torchmark shares are owned by insiders. Comparatively, 18.9% of shares of all “Life insurance” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Torchmark and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Torchmark $4.16 billion $1.45 billion 17.50
Torchmark Competitors $22.05 billion $1.24 billion 15.91

Torchmark’s peers have higher revenue, but lower earnings than Torchmark. Torchmark is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Torchmark peers beat Torchmark on 8 of the 15 factors compared.

Torchmark Company Profile

Torchmark Corporation (Torchmark) is an insurance holding company. The Company, through its subsidiaries, provides a range of life and health insurance products and annuities to a base of customers. The Company’s segments include life insurance, health insurance, annuities and investment. The life insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurance. The Health insurance products are guaranteed-renewable and include Medicare Supplement, critical illness, accident and limited-benefit supplemental hospital and surgical coverage’s. Annuities include fixed-benefit contracts. The Company markets its insurance products through various distribution channels, each of which sells the products of its insurance segments. Its subsidiaries include American Income Life Insurance Company (American Income) and Liberty National Life Insurance Company (Liberty National).

Receive News & Ratings for Torchmark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Torchmark and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply